BDBM714806 4-((5-(2,4,5-trifluoro-3- hydroxyphenyl)-1,3,4-thiadiazol-2- yl)methyl)-6-(2,2,2-trifluoroethyl)- 4,6-diazaspiro[2.4]heptane-5,7- dione::US20250026745, Compound I-68

SMILES O=C2N(CC(F)(F)F)C(=O)C1(CC1)N2Cc4nnc(c3cc(F)c(F)c(O)c3F)s4

InChI Key InChIKey=VPJKBIVUOMIBHI-UHFFFAOYSA-N

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 714806   

Target17-beta-hydroxysteroid dehydrogenase 13(Human)
Bluejay Therapeutics

US Patent
LigandPNGBDBM714806(4-((5-(2,4,5-trifluoro-3- hydroxyphenyl)-1,3,4-thi...)
Affinity DataIC50: 8.58nMAssay Description:More specifically, recombinant 17β-HSD13 protein was assayed in a buffer containing 200 mM Tris pH 7.5, 0.01% Triton X-100, and 0.02% BSA into a 384-...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In Depth
Date in BDB:
5/30/2025
Entry Details
US Patent